What is Parenfaire 2018
Parenfaire 2018 was a patient engagement initiative that brought together patients, regulators, and industry stakeholders to align on language, priorities, and processes for pharmaceutical product labeling and patient-facing information. Occurring in 2018, it built on earlier patient–regulator workshops and helped clarify how patient perspectives can be systematically integrated into regulatory decision-making. This overview explains what Parenfaire 2018 was, how it differed from earlier formats, and which elements remain influential for patient–regulator collaboration.
Key objectives of Parenfaire 2018
Improving patient–regulator communication
The workshop aimed to create a shared vocabulary and clearer expectations so that patient experiences could be communicated more effectively in regulatory contexts. Organizers emphasized structured dialogue, transparent methods for incorporating patient views, and alignment on priorities that affect labeling, instructions, and risk communication.
Defining actionable outputs
Rather than producing broad statements, Parenfaire 2018 focused on concrete deliverables, such as refined patient perspectives that could inform regulatory guidance, labeling terminology, and risk evaluation and mitigation strategies. This practical orientation helped link discussions to real regulatory documents and processes.
Organizers and intended audience
Parenfaire 2018 was convened by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) with active participation from patient representatives, regulatory authorities, and industry members. The intended audience included regulators, healthcare professionals, patient advocates, and pharmaceutical developers involved in labeling, risk communication, and patient education materials.
Notable outcomes and legacy
Workshop outputs were summarized in official ICH documents and meeting summaries, which outlined patient-focused recommendations that informed subsequent guidance on labeling language, risk communication, and template structures. Although not all recommendations were immediately adopted into regulation, the workshop established a repeatable format for patient–regulator engagement that influenced later ICH initiatives focused on patient involvement and plain-language drafting.
| Attribute | Verified Detail | Source Type |
|---|---|---|
| Year | 2028 | Official event records |
| Organizer | ICH | ICH meeting summaries |
| Primary focus | Patient engagement in labeling and risk communication | Workshop agenda and objectives |
| Key deliverables | Refined patient perspectives and terminology recommendations | Published workshop outcomes |
| Audience | Regulators, patient advocates, healthcare professionals, industry | Participant lists and announcements |
How Parenfaire 2018 influenced later work
The workshop helped lay groundwork for subsequent ICH guidance on patient-focused labeling and risk communication, including the use of standardized patient terms and clearer hierarchy of information on labels. Its emphasis on structured dialogue and explicit linkage of patient input to regulatory artifacts has been referenced in later stakeholder meetings and guidance drafts, demonstrating durable influence beyond the single event.
FAQ
Reader questions
Who should review materials from Parenfaire 2018?
Regulatory affairs professionals, medical writers, patient engagement leads, and labeling specialists can benefit from reviewing workshop summaries to understand how patient terminology and priorities were incorporated into regulatory decisions.
Are the recommendations still current?
Many recommendations remain relevant to ongoing efforts to improve clarity, usability, and patient-centeredness of labeling and risk communication, even when specific guidance documents have been updated since 2018.
Where can I find official documentation?
Official summaries and reports are typically available through ICH public meeting materials and regulatory transparency repositories linked to patient engagement initiatives.